Rocket


News + Filings
Transactions





All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other



Kim Mina Create: Alert

All | News | Filings
Date FiledTypeDescription
08/18/2023 4 Form 4 - Statement of changes in beneficial ownership of securities:
05/11/2023 4 Kim Mina (Chief Legal & Admin. Officer) has filed a Form 4 on ACELYRIN, Inc.
Txns: Bought 5,000 shares @ $18, valued at $90k
Disposed of 362,719 options to buy @ $5.8766, valued at $2.1M
Acquired 362,719 options to buy @ $5.8766, valued at $2.1M
Disposed of 85,226 options to buy @ $18, valued at $1.5M
Acquired 85,226 options to buy @ $18, valued at $1.5M
05/04/2023 4 Kim Mina (Chief Legal & Admin. Officer) has filed a Form 4 on ACELYRIN, Inc.
Txns: Granted 85,226 options to buy @ $18, valued at $1.5M
09/07/2022 4 Kim Mina (Chief Legal Officer) has filed a Form 4 on Zymergen Inc.
Txns: Sold 3,410 shares @ $2.21, valued at $7.5k
08/04/2022 4 Kim Mina (Chief Legal Officer) has filed a Form 4 on Zymergen Inc.
Txns: Sold 3,094 shares @ $2.6125, valued at $8.1k
07/07/2022 4 Kim Mina (Chief Legal Officer) has filed a Form 4 on Zymergen Inc.
Txns: Sold 2,924 shares @ $1.3223, valued at $3.9k
06/06/2022 4 Kim Mina (Chief Legal Officer) has filed a Form 4 on Zymergen Inc.
Txns: Sold 2,939 shares @ $1.6776, valued at $4.9k
05/04/2022 4 Kim Mina (Chief Legal Officer) has filed a Form 4 on Zymergen Inc.
Txns: Sold 3,206 shares @ $1.7903, valued at $5.7k
03/15/2022 4 Kim Mina (Chief Legal Officer) has filed a Form 4 on Zymergen Inc.
Txns: Granted 217,000 shares @ $0
10/28/2021 4 Kim Mina (Chief Legal Officer) has filed a Form 4 on Zymergen Inc.
Txns: Granted 97,000 shares @ $0
Granted 194,000 options @ $10, valued at $1.9M
04/10/2019 4 Kim Mina (Senior VP & General Counsel) has filed a Form 4 on Atara Biotherapeutics, Inc.
Txns: Paid exercise price by delivering 3,674 shares @ $36.85, valued at $135.4k
03/27/2019 4 Kim Mina (Senior VP & General Counsel) has filed a Form 4 on Atara Biotherapeutics, Inc.
Txns: Granted 10,000 shares @ $0
02/08/2019 4 Form 4 - Statement of changes in beneficial ownership of securities:
04/09/2018 4 Kim Mina (Senior VP & General Counsel) has filed a Form 4 on Atara Biotherapeutics, Inc.
Txns: Granted 42,500 shares @ $0
Granted 70,000 options to buy @ $36, valued at $2.5M
03/17/2017 4 Form 4 - Statement of changes in beneficial ownership of securities
11/10/2016 4 Form 4 - Statement of changes in beneficial ownership of securities

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy